Apoptosis Susceptibility and Cell-Cycle Distribution in Cells from Myelodysplastic Syndrome Patients: Modulatory In-Vitro Effects of G-CSF and Interferon-α

Reference

• Parker, E.J. and Mufti, G.J. (1998a) "Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes", British Journal of Haematology, 101, 220–230.
   PubMed Web of Science ®Google Scholar
• Yoshida, Y. (1993) "Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndromes", Leukemia, 7, 144–146.
   Google Scholar
• Raza, A., Gezer, S., Mundle, S., Gao, X-Z., Alvi, S., Borok, R., et al. (1995) "Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndrome", Blood, 86, 268–276.
   PubMed Web of Science ®Google Scholar
• Rajapaksa, R., Ginzton, N., Rott, L.S. and Greenberg, P.L. (1996) "Altered oncoprotein expression and apoptosis in myelodysplastic syndromes marrow cells", Blood, 88, 4275–4287.
   Google Scholar
• Bogdanovic, A.D., Trpinac, D.P., Jankovic, G.M., Bumbasirevic, V.Z., Obradovic, M. and Colovic, M.D. (1997) "Incidence and role of apoptosis in myelodysplastic syndromes: morphological and ultrastructural assessment", Leukemia, 11, 656–659.
   PubMed Web of Science ®Google Scholar
• Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., et al. (1997) "Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes", Leukemia, 11, 839 — 845.
   Google Scholar
• Shetty, V., Huissaini, S., Broady-Robinson, L.T., Allampallam, K., Mundle, S., Borok, R., et al. (2000) "Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates", Blood, 96, 1388–1392.
   PubMed Web of Science ®Google Scholar
• Parker, E.J., Mufti, G.J., Rasool, F., Mijovic, A., Devereux, S. and Pagliuca, A. (2000) "The role of apoptosis, proliferation, and bc1-2 related proteins in the myelodysplastic syndrome and acute myeloid leukemia secondary to MDS", Blood, 96, 3932— 3938.
   Google Scholar
• Yang, E. and Korsmeyer, S.J. (1996) "Molecular thanatopsis: a discourse on the Bc1-2 family and cell death", Blood, 88, 386–401.
   Google Scholar
• Parker, E.J., Fishloch, K.L., Mijovic, A., Czepulkowslci, B., Pagliuca, A. and Mufti, G.J. (1998b) " `Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bc1-2 related proteins", British Journal of Haematology, 103, 1075 — 1082.
   Google Scholar
• Negrin, R.S., Haeuber, D.H., Nagler, A., Olds, L.C., Donlon, T., Souza, L. et al. (1989) "Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. A phase I-II trial", Annals of Internal Medicine, 110, 976–984.
   PubMed Web of Science ®Google Scholar
• Negrin, R.S., Stein, R., Vardiman, J., Doherty, K., Cornwell, J., Krantz, S. et al. (1993) "Treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor in combination with erythropoietin", Blood, 82, 737–743.
   Google Scholar
• Hellstrom-Lindberg, E., Birgegard, G., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., et al. (1993) "A combination of granulocyte colony stimulating factor and erythropoietin may synergistically improve the anemia in patients with myelodysplastic syndromes", Leukemia and Lymphoma, 11, 221 — 228.
   Google Scholar
• Hellstrom-Lindberg, E., Negrin, R.S., Stein, R., Krantz, S., Lindberg, G., Vardiman, J., et al. (1997) "Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model", British Journal of Haematology, 99, 344–351.
   PubMed Web of Science ®Google Scholar
• Carlo-Stella, C., Cazzola, M., Ganser, A., Bergamaschi, G., Meloni, F., Pedrazzoli, P., et al. (1988) "Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syn-dromes", Leukemia, 2, 55–59.
   Google Scholar
• Galvani, D., Nethersell, A. and Bottomley, J. (1987) "Treatment of myelodysplasia with alpha-interferon", Leukemia, 1, 786–787.
   PubMed Web of Science ®Google Scholar
• Holcombe, R.F. (1993) "Mini-dose interferon alpha-2a in the treatment of myelodysplasia", Leukemia, 7, 192–195.
   PubMed Web of Science ®Google Scholar
• Petti, MC., Latagliata, R., Avvisati, R., Aloe Spiriti, M.A., Montefusco, E., Spadea, A., et al. (1996) "Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferon", British Journal of Haematology, 95, 364— 367.
   Google Scholar
• Mandelli, F., Arcese, W. and Avvisati, G. (1994) "The interferons in hematological malignancies", Bailliere's Clinical Haemotology, 7, 91 — 113.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. et al. (1982) "Proposal for the classification of the myelodysplastic syndromes", British Journal of Haematology, 51, 189 — 199.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Cox, C., LeBeau, MM., Fenaux, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079–2088.
   Google Scholar
• Tafuri, A., Lemoli, R.M., Chen, R., Gulati, S.C., Clarkson, B.D. and Andrea'', M. (1994) "Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs", Leukemia, 8, 749–757.
   Google Scholar
• Ricciardi, M.R., Petrucci, M.T., Gregorj, C., Ariola, C., Lemoli, R.M., Fogli, M., et al. (2001) "Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia", British Journal of Haematology, 113, 391 — 399.
   Google Scholar
• Tafuri, A., Lemoli, R.M., Petrucci, M.T., Ricciardi, M.R., Fogli, M., Bonsi, L., et al. (1999) "Thrombopoietin and interleulcin-11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells", Experimental Hematology, 27, 1255 — 1263.
   Google Scholar
• Huh, Y.O., Estey, E., Giles, F., Kantarjian, H., Freireich, E. and Albitar, M. (2000) . "More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia", Leukemia, 16, 2249–2252.
   Google Scholar
• Tafuri, A. and Andrea'', M. (1990) "Kinetic rationale for cytolcine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro", Leukemia, 4, 826–834.
   Google Scholar
• Selleri, C., Sato, T., Anderson, S., Young, N.S. and Maciejewslci, P.J. (1995) "Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death", Journal of Cellular Physiology, 165, 538–546.
   Google Scholar
• Maciejewski, P.J., Selleri, C., Anderson, S. and Young, N.S. (1995) "Fas antigen expression on CD34 + human marrow cells is induced by interferon y and tumor necrosis factor a and potentiates cytolcine-mediated hematopoietic suppression in vitro." Blood, 85, 3183–3190.
   PubMed Web of Science ®Google Scholar
• Santini, V. and Rossi Ferrini, P. (1998) "Differentiation therapy of myelodysplastic syndromes: fact or fiction?", British Journal of Haematology, 102, 1124 — 1138.
   PubMed Web of Science ®Google Scholar
• Bouscary, D., Chen, Y.L., Guesnu, M., Picard, F., Viguier, F., Lacombe, C., et al. (2000) . "Activity of caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony forma-tion in vitro", Experimental Hematology, 28, 784–791.
   PubMed Web of Science ®Google Scholar
• Gersuk, G.M., Beckham C., Loken, MR., Kiener, P., Anderson, J.E., Farrand, A., et al. (1998) "A role for tumor necrosis factor-alpha Fas and Fas-ligand in marrow failure associated with myelodysplastic syndromes", British Journal of Haematology, 103, 176— 188.
   Google Scholar